Effect of Combination Treatment with GLP-1 Receptor Agonist and SGLT-2 Inhibitors on Incidence of Cardiovascular and Serious Renal Events . Medical Forum Monthly, [S. l.], v. 35, n. 6, 2024. Disponível em: https://medicalforummonthly.com/index.php/mfm/article/view/4697.. Acesso em: 17 nov. 2025.